MORAN MICHAEL SHAWN (EVP, Chief Commercial Officer) received a stock award from EAGLE PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/2/2022ACC: 0001209191-22-015024
Officer· EVP, Chief Commercial Officer
Since Sep 2021
+10.40K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
10.40K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10.40K
Price / share
—
Trade value
—
% of position
47.9%
2/28/2022
21.71K→32.12K
Total
Net shares
+10.40K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/28/2022 | A · Award | +10.40K | — | — | 47.9% | 21.71K | 32.12K |
| Total | +10.40K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported